ULBI
Ultralife Corporation
NASDAQ · USIndustrialsElectrical Equipment & Parts
$5.27-4.36%
Price as of Jul 20, 2026
ULBI growth
Ultralife Corporation growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +8.4%
- EBITDA
- —
- EBIT
- -58.6%
- EPS
- —
- Free cash flow
- -65.2%
- Operating cash flow
- -50.8%
Forward estimates
- Revenue
- -37.5%
- EBITDA
- +468.7%
- EPS
- +200.5%
Three-year CAGR
- Revenue
- +13.2%
- EBITDA
- -40.3%
- EBIT
- +315.0%
- Net income
- —
- EPS
- —
- Free cash flow
- -51.6%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.